Overview
People with Parkinson’s Disease whose motor symptoms are debilitating and cannot be controlled with medications, or whose side effects from medications are severe, may be candidates for Deep Brain Stimulation… read more
Overview
Crexont is approved by the U.S. Food and Drug Administration (FDA) for the treatment of Parkinson’s disease, post-encephalitic parkinsonism (Parkinson-like symptoms following brain inflammation), and parkinsonism…